NCT00157651View on ClinicalTrials.gov

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
End Stage Renal DiseaseThrombosisBleeding
Interventions
DRUG

warfarin

Daily oral warfarin with INR monitored weekly, adjusted to keep INR between 1.5 and 1.9

DRUG

placebo

matching placebo for warfarin, adjusted according to sham INR generated by unblinded warfarin monitor

Trial Locations (1)

L8N 4A6

St. Joseph's Healthcare, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER

NCT00157651 - Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters | Biotech Hunter | Biotech Hunter